Cytotoxicity data for CLB and conjugates I–IV (1–500 μM) in MCF7 (breast adenocarcinoma), MDA-MB-231 (breast invasive ductal carcinoma), and 184B5 (normal breast) cells after 24 h. Here, CLYBL is linked to breast adenocarcinoma.